Therapeutic Effects and Mechanisms of Icaritin in Parkinson's Disease.

Parkinson's Disease (PD) is a neurodegenerative disorder of the central nervous system (CNS). Given the increasing age of the general population, PD has emerged as a significant public health and societal concern, impacting both individual well-being and socioeconomic progress. The present interventions have proven insufficient in impeding the progressive nature of PD.

The Role and Molecular Mechanism of Icaritin in the Treatment of Alzheimer's Disease.

Alzheimer's disease (AD), a degenerative disease of the central nervous system, affects approximately 70 million individuals worldwide. As the number of elderly in the population increases, the prevalence and incidence of AD are increasing annually. Although the drugs are currently used to alleviate certain cognitive symptoms, their overall therapeutic efficacy remains unclear.

The Protective Effect of SLNP on Hepatic Fibrosis Induced by Thioacetamide in Rats.

Introduction: The incidence of non-alcoholic fatty liver disease (NAFLD) has increased in recent years. Hepatic fibrosis (HF) is an important step in the progression of NAFLD to cirrhosis and even carcinoma and is also recognized as a possible reversal phase.

Aims: We previously found that the aqueous extract of Sedum Lineare Thunb.